135 related articles for article (PubMed ID: 34330651)
21. Racial/ethnic differences in upper-tract urothelial cancer.
Hosain GM; Khan MM; Amiel GE; Lerner SP; Latini DM; Chen GJ
Ethn Dis; 2012; 22(3):295-301. PubMed ID: 22870572
[TBL] [Abstract][Full Text] [Related]
22. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
[TBL] [Abstract][Full Text] [Related]
23. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Soulières D; Montanari E; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
Eur Urol Focus; 2020 Mar; 6(2):298-304. PubMed ID: 30266210
[TBL] [Abstract][Full Text] [Related]
24. PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions.
Deuker M; Stolzenbach LF; Pecoraro A; Rosiello G; Luzzago S; Tian Z; Saad F; Chun FK; Karakiewicz PI
World J Urol; 2021 Mar; 39(3):787-796. PubMed ID: 32458094
[TBL] [Abstract][Full Text] [Related]
25. Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
Incesu RB; Barletta F; Tappero S; Piccinelli ML; Garcia CC; Morra S; Scheipner L; Tian Z; Saad F; Shariat SF; Ahyai S; Longo N; Chun FKH; de Cobelli O; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Cancer Epidemiol; 2024 Apr; 89():102538. PubMed ID: 38377946
[TBL] [Abstract][Full Text] [Related]
26. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
[TBL] [Abstract][Full Text] [Related]
27. Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy.
Zamboni S; Foerster B; Abufaraj M; Seisen T; Roupret M; Colin P; De la Taille A; Di Bona C; Peyronnet B; Bensalah K; Herout R; Wirth MP; Novotny V; Soria F; Chlosta P; Antonelli A; Simeone C; Baumeister P; Mattei A; Montorsi F; Simone G; Gallucci M; Matsumoto K; Karakiewicz PI; Briganti A; Xylinas E; Shariat SF; Moschini M; ;
BJU Int; 2019 Nov; 124(5):738-745. PubMed ID: 30908835
[TBL] [Abstract][Full Text] [Related]
28. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
[TBL] [Abstract][Full Text] [Related]
29. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
Ehdaie B; Furberg H; Zabor EC; Ostroff JS; Shariat SF; Bochner BH; Coleman JA; Dalbagni G
BJU Int; 2013 Apr; 111(4):589-95. PubMed ID: 22642265
[TBL] [Abstract][Full Text] [Related]
30. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Fossati N; Gandaglia G; Gallina A; Abdollah F; Shariat SF; Montorsi F; Saad F; Tilki D; Briganti A; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):381-388. PubMed ID: 29366856
[TBL] [Abstract][Full Text] [Related]
31. Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Deuker M; Mistretta FA; Tian Z; Fossati N; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
J Surg Oncol; 2020 Jun; 121(7):1154-1161. PubMed ID: 32107785
[TBL] [Abstract][Full Text] [Related]
32. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI
Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235
[TBL] [Abstract][Full Text] [Related]
33. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
[TBL] [Abstract][Full Text] [Related]
34. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
Flammia RS; Chierigo F; Würnschimmel C; Horlemann B; Hoeh B; Sorce G; Tian Z; Leonardo C; Tilki D; Terrone C; Saad F; Shariat SF; Montorsi F; Chun FK; Gallucci M; Karakiewicz PI
Urol Oncol; 2022 Apr; 40(4):165.e9-165.e15. PubMed ID: 34686429
[TBL] [Abstract][Full Text] [Related]
35. Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Urol Oncol; 2022 Nov; 40(11):493.e9-493.e16. PubMed ID: 35907705
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Ethnicity and Age on Distribution of Metastases in Patients with Upper Tract Urothelial Carcinoma: Analysis of SEER Data.
Tufano A; Perdonà S; Viscuso P; Frisenda M; Canale V; Rossi A; Del Prete P; Passaro F; Calarco A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509582
[TBL] [Abstract][Full Text] [Related]
38. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Zhai TS; Jin L; Zhou Z; Liu X; Liu H; Chen W; Lu JY; Yao XD; Feng LM; Ye L
BMC Cancer; 2019 Dec; 19(1):1207. PubMed ID: 31830927
[TBL] [Abstract][Full Text] [Related]
39. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
40. Intravesical Recurrence After Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.
Wu J; Xu PH; Luo WJ; Dai B; Shen YJ; Ye DW; Wang YC; Zhu YP
Front Surg; 2021; 8():590448. PubMed ID: 33693025
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
